Toggle navigation
GENERAL INFORMATION
ORGANIZATIONAL INFORMATION
CHAIRS
PATRONAGE
PROGRAM
PARTNER
CONTACT
SIGN IN
ESH ONLINE
PROGRAM
3
November
Wednesday
Chairs
Csaba Farsang (Hungary) , Reinhold Kreutz (Germany)
4:00 – 4:45 PM (CET)
Pharmacology of the renin-angiotensin-aldosterone system
Jan Danser (Netherlands)
Epidemiology of resistant hypertension
Krzysztof Narkiewicz (Poland)
Chairs
Csaba Farsang (Hungary) , Reinhold Kreutz (Germany)
4:00 – 4:45 PM (CET)
Pharmacology of the renin-angiotensin-aldosterone system
Jan Danser (Netherlands)
Epidemiology of resistant hypertension
Krzysztof Narkiewicz (Poland)
10
November
Wednesday
Chairs
Csaba Farsang (Hungary) , Costas Tsioufis (Greece)
4:00 – 4:45 PM (CET)
Clinical relevance of resistant hypertension
Andrzej Januszewicz (Poland)
Drug treatment approach in resistant hypertension
Reinhold Kreutz (Germany)
Chairs
Csaba Farsang (Hungary) , Costas Tsioufis (Greece)
4:00 – 4:45 PM (CET)
Clinical relevance of resistant hypertension
Andrzej Januszewicz (Poland)
Drug treatment approach in resistant hypertension
Reinhold Kreutz (Germany)
17
November
Wednesday
Chairs
Csaba Farsang (Hungary), Andrzej Januszewicz (Poland)
4:00 – 4:45 PM (CET)
Potential role of device-based therapy in resistant hypertension
Roland Schmieder (Germany)
Overhaul on future perspective of aldosterone receptor antagonist
Philippe van de Borne (Belgium)
Chairs
Csaba Farsang (Hungary), Andrzej Januszewicz (Poland)
4:00 – 4:45 PM (CET)
Potential role of device-based therapy in resistant hypertension
Roland Schmieder (Germany)
Overhaul on future perspective of aldosterone receptor antagonist
Philippe van de Borne (Belgium)